Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767400 · ClinicalTrials.gov registry record
Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.
A clinical trial of Skin Care, sponsored by Allergan.
- Completed
- Registry status
- 99
- Enrollment target
- 1
- Study location
NCT03767400: Completed study of Skin Care, sponsored by Allergan.
NCT03767400 is a study of Skin Care that has completed, run by Allergan. The registered enrollment target is 99 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03767400, a study of Skin Care, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center clinical study is being conducted over the course of 2 weeks to conduct an exploratory pilot study as a preliminary evaluation of D-OCT's ability to measure skin changes from aging. Assess structural differences between young and aged skin on the face. To identify the structural characteristics of atrophic acne scars relative to normal skin on the face. To explore characteristics of cellulite relative to normal skin on the thigh in young and aged skin.
Primary Outcome
Epidermal thickness will be measured in microns.
Conditions Studied
Interventions
- OTHER Facial Cleanser
- DEVICE Skin Imaging
Study Locations (1)
California
- Skinmedica Clinical Research and Innovation Center - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2019-07-30 |
What the finished NCT03767400 record still lists
NCT03767400 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 1 condition, with Skin Care appearing as the primary indexed condition, and to 2 interventions - of which Facial Cleanser is the first listed.
NCT03767400 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03767400 about?
NCT03767400 is a clinical study titled "Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.". This single-center clinical study is being conducted over the course of 2 weeks to conduct an exploratory pilot study as a preliminary evaluation of D-OCT's ability to measure skin changes from aging. Assess structural differences between young and aged skin on the face. To identify the structural c...
What is the current status of trial NCT03767400?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2018-12-07. Estimated completion is 2019-07-30.
What conditions does trial NCT03767400 study?
This clinical trial studies the following conditions: Skin Care.
What interventions are being tested in trial NCT03767400?
The interventions under investigation include: Facial Cleanser (OTHER), Skin Imaging (DEVICE).
Who is sponsoring clinical trial NCT03767400?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03767400 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI